Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsEpithelial CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsCyclophosphamideHistocompatibilityCombined Modality TherapyTransplantation, IsogeneicBone Marrow DiseasesMice, Inbred C57BLKidney TransplantationTime FactorsTreatment OutcomeRecurrenceHematopoiesisRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsSurvival AnalysisRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsBone Marrow NeoplasmsBone RemodelingHepatic Veno-Occlusive DiseaseKidney NeoplasmsRetrospective StudiesTransplantation ImmunologyLeukemia, MyeloidCarcinoma, Renal CellGraft vs Host ReactionCells, CulturedImmunosuppressionStem Cell TransplantationLymphocyte DepletionLymphoma, Non-HodgkinSurvival RateCell DifferentiationAcute DiseaseCell ProliferationLeukocyte TransfusionHeart TransplantationBreast NeoplasmsFlow CytometryT-LymphocytesAntineoplastic AgentsFollow-Up StudiesColony-Forming Units AssayMice, Inbred BALB CPrognosisChimeraDisease-Free SurvivalSevere Combined ImmunodeficiencyApoptosisHLA AntigensMyelodysplastic SyndromesCell Line, TumorLung TransplantationNeoplasmsRNA, MessengerCyclosporineActuarial AnalysisEtoposideCell DivisionHematologic DiseasesTumor Cells, CulturedBone DensityLymphocyte TransfusionReverse Transcriptase Polymerase Chain ReactionAntibodies, MonoclonalNuclear FamilyGene Expression Regulation, NeoplasticCarmustineCell SurvivalOrgan TransplantationCell LinePancytopeniaGraft vs Tumor EffectCell Movement